LPA gene / apolipoprotein(a) mRNA drugs for Atherosclerotic Cardiovascular Disease
5 tracked LPA gene / apolipoprotein(a) mRNA drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the LPA gene / apolipoprotein(a) mRNA page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
2 Phase 32 Phase 21 Phase 1/2
Head-to-head evidence: Lepodisiran vs Olpasiran · Lepodisiran vs SRSD216 · Lepodisiran vs SYH2068 · Lepodisiran vs Zerlasiran · Olpasiran vs SRSD216 · Olpasiran vs SYH2068